203 related articles for article (PubMed ID: 37044278)
1. Ab Externo SIBS Microshunt with Mitomycin C for Open-Angle Glaucoma: Three-Year Results as a Primary Surgical Intervention.
Armstrong JJ; De Francesco T; Ma J; Schlenker MB; Ahmed IIK
Ophthalmol Glaucoma; 2023; 6(5):480-492. PubMed ID: 37044278
[TBL] [Abstract][Full Text] [Related]
2. All Consecutive Ab Externo SIBS Microshunt Implantations With Mitomycin C: One-Year Outcomes and Risk Factors for Failure.
Schlenker MB; Armstrong JJ; De Francesco T; Ahmed IIK
Am J Ophthalmol; 2023 Nov; 255():125-140. PubMed ID: 37352909
[TBL] [Abstract][Full Text] [Related]
3. Intermediate Outcomes of a Novel Standalone Ab Externo SIBS Microshunt With Mitomycin C.
Schlenker MB; Durr GM; Michaelov E; Ahmed IIK
Am J Ophthalmol; 2020 Jul; 215():141-153. PubMed ID: 32173344
[TBL] [Abstract][Full Text] [Related]
4. One-year outcomes of stand-alone ab externo SIBS microshunt implantation in refractory glaucoma.
Durr GM; Schlenker MB; Samet S; Ahmed IIK
Br J Ophthalmol; 2022 Jan; 106(1):71-79. PubMed ID: 33097520
[TBL] [Abstract][Full Text] [Related]
5. Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: Two-Year Results from a Randomized, Multicenter Study.
Panarelli JF; Moster MR; Garcia-Feijoo J; Flowers BE; Baker ND; Barnebey HS; Grover DS; Khatana AK; Lee B; Nguyen T; Stiles MC; Sadruddin O; Khaw PT;
Ophthalmology; 2024 Mar; 131(3):266-276. PubMed ID: 37769852
[TBL] [Abstract][Full Text] [Related]
6. Intermediate Outcomes of the Novel 63-μm Gelatin Microstent versus the Conventional 45-μm Gelatin Microstent.
Hussein IM; De Francesco T; Ahmed IIK
Ophthalmol Glaucoma; 2023; 6(6):580-591. PubMed ID: 37169174
[TBL] [Abstract][Full Text] [Related]
7. Comparing Outcomes of Trabeculotomy with Mitomycin C to 45-μm Gelatin Stent Placed Ab Externo with Open Conjunctiva.
Sabogal E; Ingram Z; Odishelidze N; El Helwe H; Falah HK; Trzcinski J; Hall N; Solá-Del Valle D
Ophthalmol Glaucoma; 2024; 7(3):232-241. PubMed ID: 38056708
[TBL] [Abstract][Full Text] [Related]
8. Safety and Effectiveness of the PRESERFLO® MicroShunt in Primary Open-Angle Glaucoma: Results from a 2-Year Multicenter Study.
Beckers HJM; Aptel F; Webers CAB; Bluwol E; Martínez-de-la-Casa JM; García-Feijoó J; Lachkar Y; Méndez-Hernández CD; Riss I; Shao H; Pinchuk L; Angeles R; Sadruddin O; Shaarawy TM
Ophthalmol Glaucoma; 2022; 5(2):195-209. PubMed ID: 34329772
[TBL] [Abstract][Full Text] [Related]
9. Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: One-Year Results from a 2-Year Randomized, Multicenter Study.
Baker ND; Barnebey HS; Moster MR; Stiles MC; Vold SD; Khatana AK; Flowers BE; Grover DS; Strouthidis NG; Panarelli JF;
Ophthalmology; 2021 Dec; 128(12):1710-1721. PubMed ID: 34051211
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of MicroShunt in Patients with Primary Open-Angle and Pseudoexfoliative Glaucoma: A Retrospective European Multicenter Study.
Fea AM; Laffi GL; Martini E; Economou MA; Caselgrandi P; Sacchi M; Au L
Ophthalmol Glaucoma; 2022; 5(2):210-218. PubMed ID: 34478904
[TBL] [Abstract][Full Text] [Related]
11. A 2-Year, Single-Center Study to Assess the Safety and Effectiveness of the MicroShunt in Primary Open-Angle Glaucoma.
Riss I
Ophthalmic Res; 2023; 66(1):206-217. PubMed ID: 36137526
[TBL] [Abstract][Full Text] [Related]
12. Clinical Outcomes and Cost Analysis of PreserFlo versus Trabeculectomy for Glaucoma Management in the United Kingdom.
Van Lancker L; Saravanan A; Abu-Bakra M; Reid K; Quijano C; Goyal S; Rodrigues I; Lascaratos G; Trikha S; Barwood C; Combe E; Kulkarni A; Lim KS; Low S
Ophthalmol Glaucoma; 2023; 6(4):342-357. PubMed ID: 36427750
[TBL] [Abstract][Full Text] [Related]
13. Mitomycin C 0.2 mg/ml vs. Mitomycin C 0.4mg/ml during the implantation of an ab externo SIBS microshunt: A mega-analysis.
De Francesco T; Armstrong JJ; Hussein IM; Costa VP; Ahmed IIK
Ophthalmol Glaucoma; 2024 Jun; ():. PubMed ID: 38851392
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, Safety, and Risk Factors for Failure of Standalone Ab Interno Gelatin Microstent Implantation versus Standalone Trabeculectomy.
Schlenker MB; Gulamhusein H; Conrad-Hengerer I; Somers A; Lenzhofer M; Stalmans I; Reitsamer H; Hengerer FH; Ahmed IIK
Ophthalmology; 2017 Nov; 124(11):1579-1588. PubMed ID: 28601250
[TBL] [Abstract][Full Text] [Related]
15. Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma.
Fontana H; Nouri-Mahdavi K; Lumba J; Ralli M; Caprioli J
Ophthalmology; 2006 Jun; 113(6):930-6. PubMed ID: 16647135
[TBL] [Abstract][Full Text] [Related]
16. Ab interno trabeculectomy versus trabeculectomy for open-angle glaucoma.
Jea SY; Francis BA; Vakili G; Filippopoulos T; Rhee DJ
Ophthalmology; 2012 Jan; 119(1):36-42. PubMed ID: 21982416
[TBL] [Abstract][Full Text] [Related]
17. Ab externo implantation of the MicroShunt, a poly (styrene-
Sadruddin O; Pinchuk L; Angeles R; Palmberg P
Eye Vis (Lond); 2019; 6():36. PubMed ID: 31807606
[TBL] [Abstract][Full Text] [Related]
18. Anterior-segment optical coherence tomography of filtering blebs in the early postoperative period of ab externo SIBS microshunt implantation with mitomycin C: Morphological analysis and correlation with intraocular pressure reduction.
Ibarz Barberá M; Morales Fernández L; Tañá Rivero P; Gómez de Liaño R; Teus MA
Acta Ophthalmol; 2022 Feb; 100(1):e192-e203. PubMed ID: 33838021
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Outcomes of Trabeculectomy Augmented with Mitomycin C Undertaken within the First 2 Years of Life.
Jayaram H; Scawn R; Pooley F; Chiang M; Bunce C; Strouthidis NG; Khaw PT; Papadopoulos M
Ophthalmology; 2015 Nov; 122(11):2216-22. PubMed ID: 26315044
[TBL] [Abstract][Full Text] [Related]
20. Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation.
Vastardis I; Fili S; Perdikakis G; Kontopoulou K; Balidis M; Gatzioufas Z; Kohlhaas M
Eye Vis (Lond); 2021 Sep; 8(1):33. PubMed ID: 34479641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
